Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 109

1.

Increased thyroid cancer risk in acromegaly.

Dagdelen S, Cinar N, Erbas T.

Pituitary. 2014 Aug;17(4):299-306. doi: 10.1007/s11102-013-0501-5.

PMID:
23836362
2.

Thyroid cancer is the most common cancer associated with acromegaly.

Gullu BE, Celik O, Gazioglu N, Kadioglu P.

Pituitary. 2010 Sep;13(3):242-8. doi: 10.1007/s11102-010-0224-9.

PMID:
20217483
3.

Prevalence of thyroid diseases in patients with acromegaly: results of an Italian multi-center study.

Gasperi M, Martino E, Manetti L, Arosio M, Porretti S, Faglia G, Mariotti S, Colao AM, Lombardi G, Baldelli R, Camanni F, Liuzzi A; Acromegaly Study Group of the Italian Society of Endocrinology..

J Endocrinol Invest. 2002 Mar;25(3):240-5.

PMID:
11936466
4.

High prevalence of differentiated thyroid carcinoma in acromegaly.

Tita P, Ambrosio MR, Scollo C, Carta A, Gangemi P, Bondanelli M, Vigneri R, degli Uberti EC, Pezzino V.

Clin Endocrinol (Oxf). 2005 Aug;63(2):161-7.

PMID:
16060909
5.

High incidence of thyroid cancer among patients with acromegaly.

Kaldrymidis D, Papadakis G, Tsakonas G, Kaldrymidis P, Flaskas T, Seretis A, Pantazi E, Kostoglou-Athanassiou I, Peppa M, Roussou P, Diamanti-Kandarakis E.

J BUON. 2016 Jul-Aug;21(4):989-993.

PMID:
27685924
6.

The occurrence of thyroid focal lesions and a need for fine needle aspiration biopsy in patients with acromegaly due to an increased risk of thyroid cancer.

Ruchala M, Skiba A, Gurgul E, Uruski P, Wasko R, Sowinski J.

Neuro Endocrinol Lett. 2009;30(3):382-6.

PMID:
19855364
7.

Tumorigenesis of papillary thyroid cancer is not BRAF-dependent in patients with acromegaly.

Kim HK, Lee JS, Park MH, Cho JS, Yoon JH, Kim SJ, Kang HC.

PLoS One. 2014 Oct 17;9(10):e110241. doi: 10.1371/journal.pone.0110241. eCollection 2014.

8.

The effects of long-term growth hormone and insulin-like growth factor-1 exposure on the development of cardiovascular, cerebrovascular and metabolic co-morbidities in treated patients with acromegaly.

Jayasena CN, Comninos AN, Clarke H, Donaldson M, Meeran K, Dhillo WS.

Clin Endocrinol (Oxf). 2011 Aug;75(2):220-5. doi: 10.1111/j.1365-2265.2011.04019.x.

PMID:
21521288
9.

Acromegaly, growth hormone and cancer risk.

Renehan AG, Brennan BM.

Best Pract Res Clin Endocrinol Metab. 2008 Aug;22(4):639-57. doi: 10.1016/j.beem.2008.08.011. Review.

PMID:
18971124
10.

Evaluation of thyroid diseases and differentiated thyroid cancer in acromegalic patients.

Dogan S, Atmaca A, Dagdelen S, Erbas B, Erbas T.

Endocrine. 2014 Feb;45(1):114-21. doi: 10.1007/s12020-013-9981-3. Epub 2013 May 14.

PMID:
23670709
11.

Goiter and impairment of thyroid function in acromegalic patients: basal evaluation and follow-up.

Cannavò S, Squadrito S, Finocchiaro MD, Curtò L, Almoto B, Vieni A, Trimarchi F.

Horm Metab Res. 2000 May;32(5):190-5.

PMID:
10871160
12.

Impact of disease activity on thyroid diseases in patients with acromegaly: basal evaluation and follow-up.

Herrmann BL, Baumann H, Janssen OE, Görges R, Schmid KW, Mann K.

Exp Clin Endocrinol Diabetes. 2004 May;112(5):225-30.

PMID:
15146366
13.

Thyroid vascularity is increased in patients with active acromegaly.

Bogazzi F, Manetti L, Bartalena L, Gasperi M, Grasso L, Cecconi E, Rago T, Pinchera A, Martino E.

Clin Endocrinol (Oxf). 2002 Jul;57(1):65-70.

PMID:
12100071
14.

Effect of growth hormone (GH) and insulin-like growth factor I on prostate diseases: an ultrasonographic and endocrine study in acromegaly, GH deficiency, and healthy subjects.

Colao A, Marzullo P, Spiezia S, Ferone D, Giaccio A, Cerbone G, Pivonello R, Di Somma C, Lombardi G.

J Clin Endocrinol Metab. 1999 Jun;84(6):1986-91.

PMID:
10372698
15.

Prevalence of thyroid diseases in patients with acromegaly: experience of a Brazilian center.

Uchoa HB, Lima GA, Corrêa LL, Vidal AP, Cavallieri SA, Vaisman M, Buescu A, Gadelha MR.

Arq Bras Endocrinol Metabol. 2013 Dec;57(9):685-90.

16.

Thyroid cancer in patients with acromegaly: a case-control study.

dos Santos MC, Nascimento GC, Nascimento AG, Carvalho VC, Lopes MH, Montenegro R, Montenegro R Jr, Vilar L, Albano MF, Alves AR, Parente CV, dos Santos Faria M.

Pituitary. 2013 Mar;16(1):109-14. doi: 10.1007/s11102-012-0383-y.

PMID:
22527615
17.

AHR over-expression in papillary thyroid carcinoma: clinical and molecular assessments in a series of Italian acromegalic patients with a long-term follow-up.

Mian C, Ceccato F, Barollo S, Watutantrige-Fernando S, Albiger N, Regazzo D, de Lazzari P, Pennelli G, Rotondi S, Nacamulli D, Pelizzo MR, Jaffrain-Rea ML, Grimaldi F, Occhi G, Scaroni C.

PLoS One. 2014 Jul 14;9(7):e101560. doi: 10.1371/journal.pone.0101560. eCollection 2014.

18.

[Acromegaly and thyroid disease: prevalence of thyroid cancer].

Marchisotti FG, Umeda LM, Zach PL, Saldanha MD, First OS, Liberman B.

Arq Bras Endocrinol Metabol. 2005 Oct;49(5):843-9. Epub 2006 Jan 23. Portuguese.

19.

Thyroid nodules in acromegaly.

Rogozinski A, Furioso A, Glikman P, Junco M, Laudi R, Reyes A, Lowenstein A.

Arq Bras Endocrinol Metabol. 2012 Jul;56(5):300-4.

20.

Supplemental Content

Support Center